Trial · NCT03977792
An Open Label Study to Evaluate the Safety and Efficacy of BOR15001L7 for the Treatment of Cold Sores in Patients With Recurrent Herpes Labialis
NCT03977792, Phase 2, Unknown, Laboratoire Boreaderme Inc.
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. An Open Label Study to Evaluate the Safety and Efficacy of BOR15001L7 for the Treatment of Cold Sores in Patients With Recurrent Herpes Labialis. Trials, record NCT03977792. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT03977792
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- An Open Label Study to Evaluate the Safety and Efficacy of BOR15001L7 for the Treatment of Cold Sores in Patients With Recurrent Herpes Labialis
- NCT number
- NCT03977792
- Status
- Unknown
- Phases
- Phase 2
- Enrollment
- 164 participants, estimated
- Lead sponsor
- Laboratoire Boreaderme Inc.
- Conditions
- Recurrent Herpes Labialis
- Interventions
- BOR15001L7, Docosanol Cream 10%
- First posted
- 2019-06-06
- Last updated
- 2020-09-07
Source ClinicalTrials.gov
Registered outcomes8
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | The mean change of healing time | Day 1 to 12 | |
| Secondary | The change in lesion rates following the prodromal stage | Day 1 to 12 | |
| Secondary | The mean change in delays (hours) between the prodromal stage and the first visible occurence of lesions | Day 1 to 12 | |
| Secondary | The percentage change in number of lesions at papule, vesicles and ulcers/soft crust, hard crust stages | Day 1 to 12 | |
| Secondary | The percentage change in dimensions (mm) of lesions at papule, vesicles and ulcers/soft crust, hard crust stages | Day 1 to 12 | |
| Secondary | The percentage of patients that demonstrated a change in intensity of drug-related symptoms (pain, tingling, itching, burning sensation) at papule, vesicles and ulcers/soft crust, hard crust stages | Day 1 to 12 | |
| Secondary | The mean change in duration (hours) of drug-related symptoms (pain, tingling, itching, burning sensation) at papule, vesicles and ulcers/soft crust, hard crust stages | Day 1 to 12 | |
| Secondary | Safety and tolerability measured by the Incidence of Treatment-Emergent Adverse Events [Side-effects] | Day 1 to 12 |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers1
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as |
|---|---|
| 28228101 | BACKGROUND |
Source PubMed
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT03977792
GET https://conductscience.org/api/trials/v1/NCT03977792/registered